MedDataX Logo

Effects of Augmented Reality on Humans

NCT ID: NCT03312790

Last Updated: 2017-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-01

Study Completion Date

2017-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nowadays, augmented reality (AR) has gained attention but little is known concerning its repercussion in individuals when considering some mental and physiological aspects. Therefore, the aim of this study was to investigate the effects of AR glasses on some cognitive and physiological functions in an attempt to determine its safety for workers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Twelve volunteers were tested during two separate randomized sessions: one with AR glasses (ARGlass) and one in normal condition (Normal). Participants had two perform different tasks of a 90 minutes total duration. Before, during and after these tasks, two feet balance, one foot balance, precision balance, stroop and memory tests were performed. Also, heart rate and electromyographic activity of some muscles were recorded. Finally a survey was filled to determine, for example fatigue, pain or comfort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Activity Mental Status Change

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

augmented reality fatigue muscle heart rate mental function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

augmented reality device

Tasks realized using augmented reality device

Group Type EXPERIMENTAL

Tasks

Intervention Type DEVICE

Augmented reality device Real condition

Real condition

Same tasks than augmented reality realized in normal/real condition

Group Type OTHER

Tasks

Intervention Type DEVICE

Augmented reality device Real condition

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tasks

Augmented reality device Real condition

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Workers tasks

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy
* BMI \< 27
* physically active
* informed consent written form

Exclusion Criteria

* in-habitual fatigue
* taking drugs and alcohol more than twice a day
* potential psychomotor disease
* injury in the preceding 3 months
* no healthcare
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Burgundy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nicolas Babault

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolas Babault, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Burgundy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre d'Expertise de la Performance - Université de Bourgogne

Dijon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Babault N, Paizis C, Deley G, Guerin-Deremaux L, Saniez MH, Lefranc-Millot C, Allaert FA. Pea proteins oral supplementation promotes muscle thickness gains during resistance training: a double-blind, randomized, Placebo-controlled clinical trial vs. Whey protein. J Int Soc Sports Nutr. 2015 Jan 21;12(1):3. doi: 10.1186/s12970-014-0064-5. eCollection 2015.

Reference Type BACKGROUND
PMID: 25628520 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.cepcometti.com

centre d'expertise de la performance

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEP1701

Identifier Type: -

Identifier Source: org_study_id